The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shukla Sanjay since 2020.
This trader's CIK number is 1671026.
At the time of last reporting, Shukla Sanjay was the President and CEO of Atyr Pharma Inc. (stock ticker symbol ATYR).
Also see all insider trading activities at Atyr Pharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ATYR | 0 | $0 | 0 | $0 | 10,375 | $0 |
| 2024 | ATYR | 20,000 | $36,140 | 0 | $0 | 10,375 | $0 |
| 2023 | ATYR | 45,000 | $64,574 | 0 | $0 | 10,375 | $0 |
| 2022 | ATYR | 30,000 | $98,385 | 0 | $0 | 0 | $0 |
| 2021 | ATYR | 12,500 | $61,537 | 778 | $5,959 | 1,785 | $0 |
| 2020 | ATYR | 6,000 | $25,619 | 745 | $3,002 | 1,786 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-03 | ATYR | Option Ex | 10,375 | .00 | 0 |
| 2024-05-31 | LIFE | Buy | 20,000 | 1.81 | 36,140 |
| 2024-02-05 | LIFE | Option Ex | 10,375 | .00 | 0 |
| 2023-12-11 | LIFE | Buy | 3,000 | 1.17 | 3,510 |
| 2023-12-12 | LIFE | Buy | 12,000 | 1.18 | 14,136 |
| 2023-11-10 | LIFE | Buy | 1,422 | 1.14 | 1,618 |
| 2023-11-13 | LIFE | Buy | 13,578 | 1.11 | 15,085 |
| 2023-07-28 | LIFE | Buy | 15,000 | 2.02 | 30,225 |
| 2023-02-03 | LIFE | Option Ex | 10,375 | .00 | 0 |
| 2022-11-21 | LIFE | Buy | 10,000 | 2.14 | 21,410 |
| 2022-07-01 | LIFE | Buy | 15,000 | 2.88 | 43,170 |
| 2022-01-07 | LIFE | Buy | 5,000 | 6.76 | 33,805 |
| 2021-11-15 | LIFE | Buy | 2,500 | 8.57 | 21,437 |
| 2021-05-18 | LIFE | Buy | 10,000 | 4.01 | 40,100 |
| 2021-02-06 | LIFE | Option Ex | 1,785 | .00 | 0 |
| 2021-02-09 | LIFE | Sale | 778 | 7.66 | 5,959 |
| 2020-06-19 | LIFE | Buy | 6,000 | 4.27 | 25,619 |
| 2020-02-06 | LIFE | Option Ex | 1,786 | .00 | 0 |
| 2020-02-07 | LIFE | Sale | 745 | 4.03 | 3,002 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shukla Sanjay (President and CEO of Atyr Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.